Form 4: Doximity Director Executes Pre-Planned Stock Sale Under Rule 10b5-1 Plan

Doximity, Inc. Director Kira Scherer Wampler converted and sold 2,000 shares of Class A Common Stock for $60.96 per share as part of a pre-arranged Rule 10b5-1 trading plan.

Summary

• Kira Scherer Wampler, a Director of Doximity, Inc., executed transactions on July 1, 2025, involving the conversion and sale of company stock.
• 2,000 shares of Class B Common Stock were converted into an equal number of Class A Common Stock shares.
• Following the conversion, 2,000 shares of Class A Common Stock were sold at a price of $60.96 per share.
• These transactions were carried out automatically under a Rule 10b5-1 trading plan, which Ms. Wampler adopted on November 12, 2024.
• After these reported transactions, Ms. Wampler directly holds 16,618 shares of Class A Common Stock.
• Additionally, Ms. Wampler retains stock options to purchase 472,700 shares of Class B Common Stock at an exercise price of $1.54 per share. These options vested in 36 equal monthly installments starting March 27, 2020, and are set to expire on June 9, 2030.

Sentiment

Score: 5

Explanation: The filing reports a routine, pre-planned insider stock sale, which is neutral in sentiment. It does not indicate any new positive or negative developments for the company.

Positives

• The stock sale was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a systematic and pre-determined transaction rather than a reactive decision based on recent company performance or news.

Negatives

• A director's sale of shares reduces their direct equity ownership in the company, which could be interpreted as a slight decrease in insider alignment, although the pre-planned nature mitigates this.

Risks

• No specific operational, financial, or strategic risks for Doximity, Inc. are disclosed in this Form 4 filing, as it is solely focused on insider trading activity.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing, as it primarily reports past and pre-planned insider transactions.

Management Comments

• No direct quotes or paraphrased statements from company management are included in this Form 4 filing.

Industry Context

This Form 4 filing reports a routine insider transaction under a pre-arranged trading plan, which is a common practice for corporate executives and directors to manage their equity holdings. It does not provide specific insights into broader industry trends or Doximity's competitive position beyond the reported stock price at the time of sale.

Related Party Transactions

• The reported transactions involve a director of Doximity, Inc. selling company stock, which is classified as an insider or related party transaction.

Stakeholder Impact

• Shareholders: The sale of shares by a director, even if pre-planned, may lead to minor concerns regarding insider confidence, but the impact is generally limited given the routine nature of Rule 10b5-1 plans.
• No direct impact on employees, customers, suppliers, or creditors is indicated by this insider trading report.

Next Steps

• No specific future actions or milestones are mentioned beyond the execution of the pre-planned trading activities.

Key Dates

Keywords

Doximity, DOCS, Form 4, Insider Trading, Stock Sale, Rule 10b5-1, Director Transaction, Equity, Class A Common Stock, Class B Common Stock